Melya Hughes Crameri

Managing Director

2010

Board of Directors · Entrepreneurship · Corporate Development · Strategy · Leadership

Partner

2015 - 2023

Non Executive Director

2017 - 2019

LSHW is a company limited by guarantee and a wholly-owned subsidiary of the Welsh Government, supporting engagement from the public and private sector to develop opportunities for improved health and wellbeing.

Founder & CEO

2011 - 2013

Caltherix Inc. - microprotein therapeutics addressing GPCRs and ion channel targets in pain and oncology

Chief Executive Officer (US) and Executive Management (CH)

2005 - 2010

President & CEO, Genetic Chemistry Inc. (Evolva US) (May 2008- June 2010) Founder, Genetic Chemistry Inc. (Evolva US) (April 2007- April 2008) VP Alliances & IP, Evolva SA (March 2005 - April 2008) Evolva/Genetic Chemistry Inc. was focused on synthetic biology approaches to discover and develop small molecule therapeutics (anti-infectives).

Business & IP Strategy Consultant

2004 - 2005

Head of Licensing & Patents

1999 - 2003

The FMI (Novartis Research Foundation) is a center for biomedical research with about 20 research groups and over 250 staff, with focus areas including oncology, metabolic disease, neurosciences, epigenetics and agribusiness.

Patent Counsel

1998 - 1999

Geron focused on stem cell therapies and inhibition of telomerase (oncology).

Patent Agent

1993 - 1998

Research Scientist

1990 - 1992